{"id":"https://openalex.org/W1983307643","doi":"https://doi.org/10.1016/j.ymthe.2006.08.684","title":"610. The Effect of In Vitro Antiviral Therapy on Lentiviral Transduction","display_name":"610. The Effect of In Vitro Antiviral Therapy on Lentiviral Transduction","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W1983307643","doi":"https://doi.org/10.1016/j.ymthe.2006.08.684","mag":"1983307643"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2006.08.684","doi":"https://doi.org/10.1016/j.ymthe.2006.08.684","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.684","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.ymthe.2006.08.684","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109965283","display_name":"Priscilla Y. Yam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priscilla Yam","raw_affiliation_strings":["Virology, Beckman Research Institute of The City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Beckman Research Institute of The City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I4387156432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023408404","display_name":"Paola Marcovecchio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paola Marcovecchio","raw_affiliation_strings":["Virology, Beckman Research Institute of The City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Beckman Research Institute of The City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I4387156432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028028396","display_name":"Shirley Xin Li","orcid":"https://orcid.org/0000-0002-7085-1850","observed_orcids":["https://orcid.org/0000-0002-7085-1850"]},"institutions":[{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shirley Li","raw_affiliation_strings":["Virology, Beckman Research Institute of The City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Beckman Research Institute of The City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I4387156432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109211673","display_name":"Jiing\u2010Kuan Yee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jiing-Kuan Yee","raw_affiliation_strings":["Virology, Beckman Research Institute of The City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Beckman Research Institute of The City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I4387156432"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105459932","display_name":"John A. Zaia","orcid":"https://orcid.org/0000-0003-4209-4888","observed_orcids":["https://orcid.org/0000-0003-4209-4888"]},"institutions":[{"id":"https://openalex.org/I4387156432","display_name":"Beckman Research Institute","ror":"https://ror.org/05fazth07","country_code":"US","type":"facility","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4387156432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Zaia","raw_affiliation_strings":["Virology, Beckman Research Institute of The City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virology, Beckman Research Institute of The City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I4387156432"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4387156432"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11401515,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":"S235","last_page":"S236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lentiviral-transduction","display_name":"lentiviral transduction","score":0.890999972820282},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.7739999890327454},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tenofovir","display_name":"tenofovir","score":0.9629999995231628},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/indinavir","display_name":"indinavir","score":0.9950000047683716},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/transduction-efficiency","display_name":"transduction efficiency","score":0.6209999918937683},{"id":"https://openalex.org/keywords/cord-blood-cd34-cells","display_name":"cord blood CD34+ cells","score":0.9129999876022339},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.5709999799728394},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5569999814033508},{"id":"https://openalex.org/keywords/gene-delivery-vectors","display_name":"gene delivery vectors","score":0.5090000033378601},{"id":"https://openalex.org/keywords/egfp-expression","display_name":"EGFP expression","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C15152581","wikidata":"https://www.wikidata.org/wiki/Q7833966","display_name":"Transduction (biophysics)","level":2,"score":0.8687779903411865},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.6179141402244568},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.6115944981575012},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.6092796921730042},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.5389730334281921},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5374091267585754},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4448346495628357},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.4257437288761139},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3971981406211853},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3963465094566345},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36081385612487793},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.3543883264064789},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2661542296409607},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.12078198790550232},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10936561226844788},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06936085224151611},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ymthe.2006.08.684","doi":"https://doi.org/10.1016/j.ymthe.2006.08.684","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.684","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2006.08.684","doi":"https://doi.org/10.1016/j.ymthe.2006.08.684","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.684","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2300673954","https://openalex.org/W2004709739","https://openalex.org/W1992463443","https://openalex.org/W4409415055","https://openalex.org/W2519264669","https://openalex.org/W41550870","https://openalex.org/W2103809350","https://openalex.org/W1967338869","https://openalex.org/W2052150955","https://openalex.org/W2062315307"],"abstract_inverted_index":{"With":[0],"the":[1,15,55,91,100,105,135,145,153,182,190,198,229,241,247,257,270,303,468],"advent":[2],"of":[3,18,57,121,137,155,181,200,240,272,305,345,347,381],"lentivirus":[4,24,83,108,424],"vector":[5,84],"(LV)-based":[6],"gene":[7,202,230,250,444],"transfer":[8,231,251,445],"research,":[9],"it":[10,451],"is":[11,436,452],"important":[12],"to":[13,235,254,432,454],"understand":[14],"potential":[16],"effect":[17,215,280,293,304,428,438],"commonly":[19,42],"used":[20,43],"anti-HIV":[21],"agents":[22,93,101,139,183],"on":[23,63,184,294,308,385],"transduction":[25,79,122,185,295,309,349],"efficiency.":[26],"One":[27],"would":[28,37],"expect":[29],"that":[30],"a":[31,49,81,291,328,376,408],"nucleoside":[32],"reverse":[33],"transcriptase":[34],"inhibitor":[35],"(NRTI)":[36],"inhibit":[38,420],"LV-transduction,":[39],"and":[40,60,98,107,116,129,163,175,195,210,213,221,237,321,383,414,426,458],"one":[41,433],"NRTI":[44,58,460],"agent,":[45],"tenofovir":[46],"(PMPA)":[47],"has":[48],"prolonged":[50],"intracellular":[51],"half-life.":[52],"To":[53,244,300],"explore":[54,302],"influence":[56],"drugs":[59],"protease":[61],"inhibitors":[62],"lentiviral":[64,348],"transduction,":[65],"cord":[66],"blood":[67,463],"CD34":[68],"were":[69,88,102,110,132,170,259,314,341],"treated":[70,89],"with":[71,80,90,134],"either":[72],"PMPA,":[73,161,456],"zidovudine":[74],"(AZT),":[75],"or":[76,312],"indinavir":[77,164,313],"before":[78,462],"recombinant":[82],"expressing":[85],"eGFP.":[86],"Cells":[87],"antiviral":[92],"in":[94,189,249,261,375,389,407],"vitro":[95],"for":[96,160,217,430,467],"24hr":[97],"then":[99],"removed":[103],"from":[104],"media":[106],"transductions":[109],"done":[111],"at":[112,152,296,316,334],"day":[113,226,286,297],"1,":[114],"3,":[115],"9":[117,227],"post-treatment.":[118,299],"The":[119,158,179],"persistence":[120],"inhibition":[123],"after":[124,205,439],"drug":[125,156,206,255],"removal":[126,207],"was":[127,150,252,327],"determined,":[128],"these":[130,138,306],"results":[131],"compared":[133],"TCID50":[136,159],"against":[140],"HIV":[141],"strain":[142],"IIIB.":[143],"For":[144],"clinical":[146],"HIV-1":[147,166],"challenge,":[148],"virus":[149],"added":[151,315],"time":[154],"removal.":[157],"AZT,":[162,457],"vs":[165],"by":[167,208,331,350,423],"p24":[168],"ELISA":[169],"(1.4\u20133.2)":[171],"\u03bcM,":[172],"27":[173],"nM":[174,177],"(5.2\u201358)":[176],"respectively.":[178],"effects":[180],"efficiency":[186,232,422],"are":[187,465],"shown":[188],"table":[191,374,406],"below.":[192],"Both":[193],"PMPA":[194,266,311,332,384,413],"AZT":[196,275,415],"reduced":[197],"level":[199],"post-transduction":[201],"expression":[203],"24-hr":[204],"69%":[209],"86%,":[211],"respectively,":[212,239],"this":[214,427],"persisted":[216],"three":[218],"days":[219],"(28%":[220],"86%":[222],"inhibition,":[223],"respectively).":[224],"By":[225],"post-treatment,":[228],"had":[233,289],"returned":[234],"92%":[236],"81%,":[238],"untreated":[242],"control.":[243],"determine":[245],"if":[246],"decrease":[248],"due":[253],"toxicity,":[256],"cells":[258,464],"placed":[260],"methylcellulose":[262],"colony":[263],"forming":[264],"assay.":[265],"did":[267,276],"not":[268],"affect":[269],"number":[271],"CFUs":[273],"but":[274,337],"have":[277],"an":[278],"inhibitory":[279],"(see":[281],")":[282],"which":[283],"lasted":[284],"until":[285],"5.":[287],"Indinavir":[288],"only":[290],"small":[292],"1":[298,359],"further":[301,339],"antivirals":[307],"efficiency,":[310],"2,":[317],"24,":[318],"36":[319],"72,":[320],"96":[322],"hrs":[323,336],"AFTER":[324],"transduction.":[325],"There":[326,435],"40%":[329],"reduction":[330],"treatment":[333],"2":[335,440],"no":[338],"reductions":[340],"observed.":[342],"Tabled":[343,379],"1Percentage":[344],"Inhibition":[346],"anti-HIV-1":[351],"agentsDays":[352],"post":[353,391],"RxUntreatedPMPA":[354],"5":[355,393],"uMAZT":[356,394],"100":[357,395],"uMIndinavir":[358],"uMDay":[360,396],"106":[361],"98":[362],"62":[363],"7Day":[364],"302":[365],"88":[366],"30Day":[367],"502":[368],"77":[369],"90Day":[370],"9081":[371],"90":[372],"Open":[373,405],"new":[377,409],"tab":[378,410],"1Effect":[380],"AZR":[382],"hematopoietic":[386],"progenitor":[387],"colonies":[388],"methylcelluloseDays":[390],"RxmockuntreatedPMPA":[392],"11091021131":[397],"4Day":[398],"31371247":[399],"23":[400],"9Day":[401],"59":[402],"21658":[403],"4108":[404],"In":[411,443],"conclusion,":[412],"exposure":[416],"pre-treatment":[417],"can":[418],"significantly":[419],"tbransduction":[421],"vectors,":[425],"lasts":[429],"up":[431],"week.":[434],"little":[437],"hours":[441],"post-transduction.":[442],"research":[446,469],"studies":[447],"involving":[448],"HIV/AIDS":[449],"patients,":[450],"warranted":[453],"stop":[455],"other":[459],"therapies":[461],"collected":[466],"transductions.":[470]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}